Company intelligence / Profile preview

Leerink Pharmaceutical Investments

Boston, Massachusetts, United States

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Leerink Partners is a leading investment bank specializing in the healthcare and life sciences sectors. The firm provides a comprehensive range of financial services, including equity research, corporate finance, mergers and acquisitions advisory, and asset management tailored specifically to biotech, pharmaceutical, and medical technology companies. Following a management buyout from SVB Financial Group in 2023, the firm returned to its independent roots as Leerink Partners. It is widely recognized for its deep industry expertise and its role in facilitating significant capital raises and strategic transactions within the global healthcare ecosystem.

Industry: Investors

Beyond the preview

Go deeper on Leerink Pharmaceutical Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leerink Pharmaceutical Investments.

Explore the full profile